The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Esperion Therapeutics, Inc(NASDAQ:ESPR) 
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic aci...
Website: http://www.esperion.com
Founded: 1998
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology
Esperion Therapeutics Days Payable Outstanding ttm (DPO)
Esperion Therapeutics Days Receivable Outstanding ttm (DSO)
Esperion Therapeutics Days Inventory Outstanding ttm (DIO)
Esperion Therapeutics Op Cashflow Per Share ttm
Esperion Therapeutics Free Cashflow Per Share ttm
Esperion Therapeutics Cash Per Share ttm
Esperion Therapeutics P/S ratio ttm
Esperion Therapeutics (GAAP) P/E ratio ttm
Esperion Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.